dCELL Vascular Patch Gains CE Mark, Tissue Regenix
Tissue Regenix received EU CE Marking for its dCELL vascular patch. The dCELL vascular patch is a sterile, non-cellular biological “scaffold” which is intended to be permanently implanted into the human body for vascular repair.
The dCell vascular patch removes cells from human and animal body parts to create a scaffold which can be used to replace worn out or diseased body parts, without the need for anti-rejection drugs.
Referencing our 6/4/10 blog: Tissue Regenix joined AIM (the Alternative Investment Market) in June via a reverse takeover of Oxeco, will manufacture the dCELL vascular patch at its York, UK facility. Tissue Regenix will now be simultaneously working towards receiving FDA approval for the US. The next product on which Tissue Regenix intends to focus is the dCELL meniscus, which helps to repair knees.
